FOSL2 and pulmonary fibrosis: Fra-2 transgenic (Fra-2Tg) mice exhibit spontaneous pulmonary fibrosis, and administration of Fra-2 inhibitors reduces ColVI expression and improves fibrosis in Fra-2Tg mice and a mouse model of pulmonary fibrosis [151].